Your session is about to expire
← Back to Search
Device
Home-based Transcranial Direct Current Stimulation (tDCS) for Major Depressive Disorders (MDD)
N/A
Waitlist Available
Research Sponsored by Neuroelectrics Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to the 4-week follow-up
Awards & highlights
No Placebo-Only Group
Summary
This trial will test the feasibility of using tDCS to treat people with depression at home. If it is successful, it could lead to more widespread use of this treatment.
Eligible Conditions
- Depression
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from baseline to the 4-week follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to the 4-week follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Incidence of Serious Adverse Events (SAE)
Median percentage change in Montgomery-Asberg Depression Mood Rating Scale (MADRS) scores
Percentage of incomplete and missed sessions (%)
Secondary study objectives
Change in the Quality of Life Enjoyment and Satisfaction Questionnaire Short Form (Q-LES-Q-SF) score
Change in the Quick Inventory of Depressive Symptomatology (QIDS-SR) score
Response rate
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Single armExperimental Treatment1 Intervention
All patients will receive active treatment which consists of stimulation (tDCS) applied using the Starstim device, with current delivered via four Starstim Pi electrodes (circular electrodes with a contact of area of 3.14 cm2) embedded in the headpiece. All study subjects will use the same fixed montage (electrode locations and currents).
Find a Location
Who is running the clinical trial?
Neuroelectrics CorporationLead Sponsor
7 Previous Clinical Trials
398 Total Patients Enrolled
1 Trials studying Depression
60 Patients Enrolled for Depression